Organon & Co (OGN)
Debt-to-equity ratio
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | 8,751,000 | 8,646,000 | 8,722,000 | 8,703,000 | 8,905,000 | 8,691,000 | 8,884,000 | 9,085,000 | 9,125,000 |
| Total stockholders’ equity | US$ in thousands | -70,000 | -589,000 | -555,000 | -737,000 | -892,000 | -1,066,000 | -1,137,000 | -1,250,000 | -1,508,000 |
| Debt-to-equity ratio | — | — | — | — | — | — | — | — | — |
December 31, 2023 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $8,751,000K ÷ $-70,000K
= —
As no specific data for Organon & Co.'s debt-to-equity ratio is provided in the table across the quarters of 2022 and 2023, a detailed analysis of the trend or pattern in this financial ratio cannot be determined at this time. The debt-to-equity ratio is a key indicator of a company's financial leverage and risk profile, showing the proportion of debt financing relative to equity financing. Without the specific ratio values, it is challenging to assess how Organon & Co. has been managing its capital structure over the past eight quarters. For a more in-depth analysis and insights into the company's financial health and risk exposure, specific numerical values of the debt-to-equity ratio would be required.
Peer comparison
Dec 31, 2023